Applied precision medicine in metastatic pancreatic ductal adenocarcinoma
H Taghizadeh, L Müllauer, RM Mader… - Therapeutic …, 2020 - journals.sagepub.com
Background: Metastatic pancreatic ductal adenocarcinoma (mPDAC) bears a dismal
prognosis due to the limited activity of systemic chemotherapy. In our platform for precision …
prognosis due to the limited activity of systemic chemotherapy. In our platform for precision …